Behavioral variant frontotemporal dementia and semantic dementia have been associated with striatal degeneration, but few studies have delineated striatal subregion volumes in vivo or related them to the clinical phenotype. We traced caudate, putamen, and nucleus accumbens on magnetic resonance images to quantify volumes of these structures in behavioral variant frontotemporal dementia, semantic dementia, Alzheimer disease, and healthy controls (n = 12 per group). We further related these striatal volumes to clinical deficits and neuropathologic findings in a subset of patients. Behavioral variant frontotemporal dementia and semantic dementia showed significant overall striatal atrophy compared with controls. Moreover, behavioral variant frontotemporal dementia showed panstriatal degeneration, whereas semantic dementia featured a more focal pattern involving putamen and accumbens. Right-sided striatal atrophy, especially in the putamen, correlated with the overall behavioral symptom severity and with specific behavioral domains. At autopsy, patients with behavioral variant frontotemporal dementia and semantic dementia showed striking and severe tau or TAR DNA-binding protein of 43 kDa pathology, especially in ventral parts of the striatum. These results demonstrate that ventral striatum degeneration is a prominent shared feature in behavioral variant frontotemporal dementia and semantic dementia and may contribute to the social-emotional deficits common to both disorders.
F rontotemporal dementia (FTD) describes a group of clinical syndromes united by underlying frontotemporal lobar degeneration (FTLD) pathology. Consistent with this nomenclature, FTD has long been associated with focal cortical atrophy, whereas subcortical structures have received less emphasis. In the behavioral variant of FTD (bvFTD) and semantic dementia (SD), however, dramatic changes in eating, sexual conduct, and compulsivity emerge, all of which may relate to striatal dysfunction. [1] [2] [3] [4] [5] [6] Later-stage patients often show extrapyramidal motor signs, such as rigidity and bradykinesia, which may reflect a loss of nigrostriatal projection targets. 7 Considering recent functional imaging evidence that neurodegenerative syndromes cause atrophy within functionally interconnected neural systems, 8 the specific subcortical regions affected by the canonical cortical dementias merit further exploration.
Previous work on FTD-related striatal involvement has been limited by methodological factors or project scope, and no study has assessed all striatal subregions at once using manual volumetric methods. Some voxel-based morphometry (VBM) studies [9] [10] [11] [12] and other automated imaging analyses 13, 14 have emphasized striatal disease, but VBM may overestimate striatal atrophy due to spatial misregistration near the ventricles. 15 Previous work from our group 16 used manual region-of-interest (ROI) tracings to confirm caudate and putamen atrophy detected by VBM in a small group of pathologically diagnosed FTLD patients. Manual ROI tracing studies further showed caudate 17 and putamen 18 atrophy in FTD subtypes but did not relate subregion volumes to behavior, histopathology, or each other, and there are no quantitative data available regarding nucleus accumbens (NAcc) volume. Studies on abnormal eating 1, 19 and motor stereotypies 20 have used VBM to link striatal atrophy to behavior but did not resolve subregionspecific correlations. Patients with bvFTD often show marked striatal degeneration at autopsy, but few studies have characterized postmortem striatal volume loss 21 or histopathology, [22] [23] [24] and pathologic studies can rarely shed light on early-stage disease. In SD, an anterior temporal disease, striatal injury remains minimally studied despite robust connections between the temporal pole and the ventral striatum in the healthy brain. 14, 25, 26 The current FTLD pathologic nomenclature is based on the protein composition of neuronal and glial inclusions, with most patients showing either tau (FTLD-tau) or transactive response DNA-binding protein of 43 kDa (TDP-43, FTLD-TDP) immunoreactive inclusions, and a small proportion showing fused in sarcoma (FUS) immunoreactive inclusions only (FTLD-FUS). 27, 28 Patients with bvFTD are divided evenly among FTLD-tau and FTLD-TDP, whereas most with SD show FTLD-TDP pathology, type C, 29 characterized by a lack of cortical neuronal cytoplasmic inclusions (NCIs) in favor of long, swollen dystrophic neurites (DNs) in superifical layers. 22, 30, 31 Interestingly, a survey of subcortical pathology in FTLD-TDP 22 described Pick body-like putaminal NCIs in SD (FTLD-TDP, type 1, now referred to as type C), suggesting that NCIs may be more prevalent in this subtype than previously recognized and restricted to subcortical structures.
We sought to fill a lingering gap in the literature by determining specific patterns of caudate, putamen, and NAcc atrophy in bvFTD and SD compared with healthy controls (HC) and Alzheimer disease (AD). On the basis of the concept of network-based neurodegeneration 8 and known patterns of corticostriatal connectivity, 25 we hypothesized that bvFTD would be associated with panstriatal injury, whereas SD would show a more ventral pattern with prominent NAcc degeneration. In patients for whom behavioral data were available, we explored the relationship between behavioral symptoms and striatal subregion volumes, predicting that reward-related behaviors, such as aberrant motor behaviors and eating disorder, would correlate with NAcc atrophy. Finally, to generate hypotheses regarding the mechanisms of striatal injury, we examined neuropathologic materials from selected patients with FTLD who had undergone autopsy.
METHODS

Subjects
Forty-eight subjects were selected from the University of California at San Francisco (UCSF) Memory and Aging Center database. Subjects belonged to the following groups: HC (n = 12), probable AD (n = 12), bvFTD (n = 12), and SD (n = 12). All subjects were evaluated by a multidisciplinary team that included a neurologist, a neuropsychologist, and a nurse, and were reviewed at a consensus conference as described previously. 32 Patients were diagnosed according to consensus clinical diagnostic criteria. 33, 34 For SD, patients with both left-temporal (n = 8) and right-temporal (n = 4) predominant presentations 4 were included, as long as they met the research criteria for SD. In keeping with the research criteria for all groups, no specific magnetic resonance imaging (MRI) atrophy pattern was required for diagnosis. Community-dwelling volunteers who lacked a neurological or psychiatric history, structural disease on MRI, or a Clinical Dementia Rating (CDR) scale score > 0 were recruited as healthy control subjects.
Subject selection proceeded as follows: because fewer bvFTD and SD subjects were available in the database at the time of sample selection, these subjects were identified first, on the basis of availability of a high-quality 1.5 T MRI scan obtained within 3 months of diagnosis. Forty-five bvFTD and 19 SD subjects met these entry criteria at the time of group selection. From these pools, 12 bvFTD and 12 SD subjects were matched to each other, as closely as possible, for age, sex, and education. Patients with available neuropsychological, behavioral, and motor data were included whenever possible within matching constraints. To limit disease severity effects on group differences, we further matched for mini mental state examination (MMSE). Next, we selected 12 patients with probable AD and 12 HC subjects to match the bvFTD and SD groups, again using age, sex, education, and MMSE (for AD only). Group demographic and neuropsychological variables are shown in Table 1 . As a result of the matching procedure, groups did not significantly differ in age, sex, or education. In addition, patient groups did not significantly differ in MMSE, CDR, or disease duration ( Table 1) .
All subjects or their surrogates provided informed consent, and the study was approved by the UCSF Committee on Human Research.
MRI Acquisition and Preprocessing
MRI scans were obtained on a 1.5 T MR scanner (Siemens Inc., Iselin, NJ) equipped with a standard quadrature head coil. Structural MRI sequences, detailed previously, 9 were chosen to obtain proton density, T1-weighted, and T2-weighted images, covering the entire brain. The T1weighted images used as the primary basis for tracing were obtained using a volumetric magnetization-prepared rapidgradient echo MRI (repetition time/echo time/inversion time = 10/4/300 ms), with a 15-degree flip angle, coronal orientation perpendicular to the double spin echo sequence, 1.0 Â1.0 mm 2 in-plane resolution, and 1.5-mm slab thickness.
MRIs were analyzed on a Linux workstation using the BRAINS2 software package. BRAINS2 is developed and made freely available by the Mental Health Clinical Research Center at the University of Iowa. 35 The T1-weighted images were resampled to 1.0 mm 3 voxels and spatially realigned so that the anteroposterior axis of the brain was realigned parallel to the anterior commissure-posterior commissure line, and the interhemispheric fissure was aligned with the other 2 orthogonal axes. The Talairach grid 36 was warped onto the resampled and spatially realigned T1-weighted images using the outermost boundaries of the cortex, the anterior commissure, and the posterior commissure as landmarks. The T2-weighted and proton density-weighted images were then realigned to the T1weighted image with an automated image registration program. 37 A discriminant analysis method based on automated training class selection 38 was applied to the coregistered images to resample images into gray matter, white matter, and cerebrospinal fluid. This tissue classification algorithm uses a Bayesian classifier based on discriminant analysis to reduce the variability in signal intensity across individual image sets and to correct for partial volume effects. This step requires the manual tracing of venous blood but is able to perform "plug" selection for gray matter, white matter, and cerebrospinal fluid. The resulting segmented image was used to facilitate manual ROI tracing, but the boundaries of the ROIs suggested by these images were not considered equivalent to the spatial extent of the ROIs. Instead, ROIs were traced according to standardized anatomic landmarks, as described below. Finally, we generated a brain mask using a previously trained artificial neural network, a feature of the BRAINS2 software package. An automated Talairach-based method of regional classification was used to calculate lobar volumes. 35 The total cerebral volume (TCV) was assessed by summing frontal, temporal, parietal, and occipital lobar volumes. The total intracranial volume (TIV) was calculated as the sum of the volumes from all 3 tissue compartments within a separate mask of all intracranial contents.
ROI Tracing and Volume Measurement
A single investigator (C.H.) blinded to all clinical and pathologic information manually traced caudate, putamen, and NAcc ROIs on MR images of all 48 subjects. This investigator was trained extensively before data collection began by tracing regions of interest for subjects not included in the study. These trial runs were reviewed by a neurologist with neuroimaging and anatomic expertise (W.W.S.) to identify tracing errors and to make appropriate adjustments. After training was completed, experimental tracings began, and reliability assessments were incorporated as described below.
All tracings were performed with 3 orthogonal planes in view. T1-weighted and T2-weighted images were superimposed on segmented images to allow toggling between images that facilitated landmark identification. ROI tracing was performed directly on T1-weighted coronal images and proceeded from anterior to posterior. Structures in the left hemisphere were drawn first for each subject. Subregions were traced using the following anatomic boundaries: (1) caudate: anterior = termination of the caudate head; medial = frontal horn of the lateral ventricle; lateral = internal capsule; inferior = the genu of the corpus callosum or, more posteriorly, the NAcc; posterior = tail of the caudate no longer visible or curves inferoposteriorly past the thalamus; (2) putamen: anterior = initial bifurcation of striatal mass by internal capsule; medial = NAcc and the anterior limb of internal capsule (anteriorly) or globus pallidus and genu of internal capsule (posteriorly); lateral = external capsule (care was taken to exclude the claustrum when visible); superior and inferior = surrounding white matter; posterior = putamen no longer visible; (3) NAcc: anterior = posterior portion of ventral caudate head, where T1 hypointense signal contour begins; medial = white matter superior to posterior orbital cortex; lateral = anterior limb of internal capsule, or, more posteriorly, the putamen; inferior = continuation of preorbital white matter; posterior = emergence of anterior commissure. Group-representative tracings and 3D ROI reconstructions are shown in Figure 1A , which features the first subject whose total striatal volume was above their diagnostic group median. Areas outlined by each ROI tracing were multiplied by the slice thickness to yield an ROI volume for that scan, and the resulting volumes were summed to yield a total volume for each structure in cubic centimeters (cc). We elected not to trace globus pallidus or thalamus because the boundaries of these structures could not be reliably visualized on our MR images.
Reliability
To assess intrarater reliability, C.H. retraced all ROIs for 4 randomly selected subjects (3 bvFTD, 1 control; the interval between original tracings and reliability tracings ranged from 15 to 19 mo). The goal of this intrarater assessment was to assess the degree of rater drift throughout the experiment. Although only C.H.'s original tracings were used for study-related hypothesis testing, to determine the reproducibility of our tracing methods, we also assessed the interrater reliability by having a second similarly trained investigator (A.H.) trace the same 4 scans used for the intrarater assessment. For intrarater reliability, intraclass correlation coefficients (ICCs, consistency model) ranged from 0.78 to 0.91 (left caudate = 0.79, left putamen = 0.91, left NAcc = 0.91; right caudate = 0.79, right putamen = 0.90, right NAcc = 0.78). These reliability data, which characterize the rater who performed all tracings used for hypothesis testing, suggest that intrarater drift throughout the experiment was mild. Interrater reliability was generally high, with ICCs (absolute agreement model) ranging from 0.66 to 0.96 (left caudate = 0.96, left putamen = 0.95, left NAcc = 0.93; right caudate = 0.90, right putamen = 0.91, right NAcc = 0.66). Because the right NAcc interrater reliability was lower than that seen for any other region, we performed a third analysis to assess the agreement across all 3 right NAcc measurements (original, intrarater, and interrater). This ICC (absolute agreement model) was 0.80, suggesting that our methods for assessing the right NAcc volume produce an acceptable overall reliability. All statistical analyses were implemented in SPSS 15.0 software (SPSS Inc., Chicago, IL).
Motoric and Behavioral Assessment
A subset of 21 patients (6 AD, 7 bvFTD, 8 SD) had a standardized prospectively recorded neurological examination in the database. From this dataset, we extracted the 10 items relating to parkinsonian signs [facial expression (0 to 4), rest tremor (0 to 4), postural tremor (0 to 4), rigidity (0 to 4), posture (0 to 4), gait (0 to 4), body bradykinesia (0 to 4), cogwheeling (0 to 3), reduced armswing (0 to 3), dyskinesia (0 to 3)], and 2 items relating to the presence of myoclonus (0 to 3) or disrupted Luria hand motor sequences (0 to 4). We then derived total scores for the motor examination (maximum = 44, with higher scores indicating greater deficits) for correlation with regional volumes. Neuropsychiatric index (NPI) data were available for 22 patients (7 AD, 8 bvFTD, 7 SD). We selected euphoria, apathy, disinhibition, aberrant motor, and eating subscales, and the NPI total score (frequencyÂ severity products), because these measures best capture the bvFTD and SD behavioral profile. 32 
Neuropathology
Although patients were selected solely on the basis of clinical syndrome, neuropathologic diagnoses were or became available for 7 AD, 9 bvFTD, and 6 SD subjects. Autopsies were performed at the University of Pennsylvania, UCSF, or the University of Southern California (1 patient) using standard dementia protocols described previously. 16 Pathologic FTLD and AD were diagnosed according to the current consensus criteria, 28, 39 and FTLD-TDP subtyping followed the recently harmonized lettering scheme. 29 All 7 patients with clinical AD had high-likelihood AD at autopsy, 1 with comorbid Lewy body pathology (diffuse neocortical type). In the bvFTD group, 4 patients had Pick disease, 1 had corticobasal degeneration, 1 had FTLD-TDP, type A, 1 had FTLD-TDP, type B, 1 had high-likelihood AD, and 1 had FTLD with FUS immunoreactive inclusions, the atypical FTLD-U subtype. 27 In the SD group, 5 patients had FTLD-TDP type C, and 1 patient had FTLD with tau-negative, ubiquitin-positive intraneuronal inclusions (FTLD-U) that were not characterized (using TDP-43 or FUS immunohistochemistry) or subtyped according to pathomorphology and laminar distribution. 29 Having identified striatal atrophy in patients with bvFTD and SD, we explored striatal histopathologic features among patients neuropathologically evaluated at UCSF, including 2 with bvFTD (1 with corticobasal degeneration; 1 with FTLD-TDP, type A) and 4 with SD (all with FTLD-TDP, type C). Relevant 8-mm-thick, paraffin-embedded fixed tissue sections were immunostained for hyperphosphoryated tau (CP13 antibody, courtesy of Peter Davies), ubiquitin (antirabbit, 1:1000, DAKO North America, Carpinteria, CA), or TDP-43 (antirabbit, 1:2000, Proteintech Group, Chicago, IL) as appropriate and were examined qualitatively for the abundance and distribution of NCIs, DNs, neuronal intranuclear inclusions, and glial cytoplasmic inclusions.
Statistical Methods
Demographic and neuropsychological variables were compared across groups using 1-way analysis of variance, with post hoc Tukey tests for pairwise comparisons, or w 2 tests, as appropriate (Table 1) . To assess the effect of the diagnostic group on each striatal subregion, we used repeated-measures 1-way analysis of variance, treating each subregion volume as a single dependent variable, with side (left or right) as the within-subjects factor and diagnosis as the between-subjects factor. The TIV was entered as a covariate, and a post hoc Bonferroni correction for pairwise multiple comparisons was applied. To determine whether between-group differences in striatal subregion atrophy could be attributed to overall brain atrophy, we repeated the primary analyses after adding TCV as a covariate. For clarity, we used TIV-corrected group-level striatal subregion volumes to calculate group percentage differences (Results) and for illustration ( Fig. 1B) .
Correlations between left and right subregion volumes were examined using partial correlation, controlling for age, sex, and TIV. We further assessed relationships between ROI volumes and the NPI (patients only, examining behavioral subscales and the total score as described above) using partial correlations (1-tailed), first controlling for TIV only and correcting for multiple comparisons using the Bonferroni method. Correlations significant at the Bonferroni-corrected threshold were then reanalyzed, controlling for TIV and diagnosis (coded using dummy variables that represented the 3 patient groups), to determine whether the observed behavioral correlations were attributable to the diagnostic group membership. Finally, in a similar manner, we controlled for TIV, diagnosis, and TCV. For the analyses in which diagnosis and TCV were included, we accepted a statistical significance of P < 0.05. To evaluate the relationship between striatal ROI volumes and motor deficits, we used Spearman correlations (1-tailed) because the motor exam scores were nonnormally distributed. Therefore, we corrected the striatal subregion volumes for TIV by multiplying each volume by the ratio of the overall sample mean TIV and the subject's TIV. One-tailed tests were used for the behavioral and motor correlations because only an inverse relationship between volume and symptom severity was considered as biologically plausible.
RESULTS
Group Differences in Striatal Volumes
Examining the impact of the diagnostic group on the total and the subregional striatal volume, we found a significant main effect of diagnosis on the total striatal volume (F = 9.33, P = 0.00007) and for all 3 subregions, including caudate (F = 7.48, P = 0.0004), putamen (F = 7.48, P = 0.0004), and NAcc (F = 10.45, P = 0.00003). In Figure 1B , TIV-corrected volume means are displayed for each subregion to highlight the results of the post hoc pairwise comparisons, detailed in the following 4 sections.
Total Striatum
Patients with bvFTD (TIV-corrected mean total striatal volume = 5.89 cc, s.d. = 1.58) had 25% lower total striatal volumes than HC (mean = 7.81 cc, s.d. = 0.81, P = 0.0002) and 20% lower total striatal volumes than AD (mean = 7.39 cc, s.d. = 0.62, P = 0.003). Patients with SD (mean = 6.34 cc, s.d. = 1.05) had 19% lower total striatal volumes than HC (P = 0.009) but did not differ from those with AD (P = 0.1). No difference in total striatal volume between bvFTD and SD was detected, and there was no overall interaction between diagnostic group and side (F = 0.87, P = 0.47).
Caudate
Patients with bvFTD (TIV-corrected mean caudate volume = 2.81 cc, s.d. = 0.79) had 20% lower caudate volumes than HC (mean = 3.5 cc, s.d. = 0.47, P = 0.01) and 23% lower volumes than AD (mean = 3.67 cc, s.d. = 0.39, P = 0.001), whereas patients with SD (mean = 3, s.d. = 0.52) had 18% lower volumes than AD (P = 0.02) but did not differ significantly from controls. AD showed no caudate atrophy compared with controls (P = 1.0). There were no group differences in caudate volume between bvFTD and SD, and there was no overall interaction between diagnostic group and side (F = 0.77, P = 0.52).
Putamen
Patients with bvFTD (TIV-corrected mean putamen volume = 2.88 cc, s.d. = 0.82) had 28% lower putaminal volumes than HC (mean = 3.97 cc, s.d. = 0.54, P = 0.0003), and patients with SD (mean = 3.15 cc, s.d. = 0.59) had 21% lower volumes than HC (P = 0.01). AD putaminal volumes (mean = 3.46 cc, s.d. = 0.40) did not show significant atrophy compared with HC (P = 0.3), nor did they differ from bvFTD (P = 0.1) or SD (P = 1). There were no differences in putaminal volume between bvFTD and SD, and there was no interaction between diagnostic group and hemisphere (F = 0.54, P = 0.66).
NAcc
Patients with bvFTD (TIV-corrected mean NAcc volume = 0.21 cc, s.d. = 0.08) had 40% lower NAcc volumes than HC (mean = 0.35 cc, s.d. = 0.07, P = 0.0002), and patients with s.d. (mean = 0.19 cc, s.d. = 0.07) had 44% lower volumes than HC (P = 0.00006). AD (mean = 0.26 cc, s.d. = 0.08) showed a trend toward NAcc atrophy compared with HC that did not reach statistical significance (P = 0.06). There were no group differences in NAcc volume between AD, bvFTD, and SD, but there was a significant interaction between the diagnostic group and side (F = 5.55, P = 0.003), with bvFTD showing smaller right-sided NAcc volumes and SD showing smaller left-sided NAcc volumes.
Striatal Volume Losses Exhibit High Interhemispheric Correlation and Cannot be Attributed to Cortical Volume Loss Alone
As shown in Figure 2 , left and right hemisphere striatal subregion volumes were highly correlated with each other (caudate r = 0.78, putamen r = 0.87, NAcc r = 0.86; all P < 0.001). To determine whether striatal atrophy in bvFTD and SD merely reflected the overall cortical volume loss, we repeated each analysis presented in the preceding section including TCV as a covariate. The total striatum volumes remained significantly atrophied in bvFTD compared with AD (P = 0.03), and caudate volumes remained significantly atrophied in bvFTD (P = 0.01) and SD compared with AD (P = 0.02). Putamen and NAcc volumes no longer showed significant group differences after correcting for TCV. Together, these findings suggest that the striatal volume loss in FTD cannot be attributed to cortical atrophy alone, especially in the caudate nucleus, but that the cortex and striatum may also codegenerate in FTD, especially within ventral corticostriatal networks.
Striatal Atrophy Correlates With Behavioral but not Motor Deficits
Correlations between striatal subregion volumes and behavior are detailed in Table 2 and summarized here. Although several striatum-NPI relationships of interest were identified in exploratory analyses not corrected for multiple comparisons (Table 2) , the right putamen and the right total striatal volumes each remained significantly correlated with aberrant motor behavior and NPI total after correction. These correlations remained significant at the P < 0.05 level after further controlling for diagnosis, and the correlation between the right putaminal volume and aberrant motor behavior remained after controlling for both diagnosis and TCV.
Patient groups did not differ significantly on the total motor examination score (AD mean = 4.7, s.d. = 2.7, n = 6; bvFTD mean = 8.0, s.d. = 7.8, n = 7; SD mean = 2.3, s.d. = 2.0, n = 8), and there were no significant correlations across groups (n = 21) between total motor examination scores and striatal volumes (total striatum, Spearman r = 0.08, P = 0.37; caudate, Spearman r = 0.20, P = 0.18; putamen, Spearman r = À0.04, P = 0.44; NAcc, Spearman r = 0.12, P = 0.30).
Relationships Between Striatal Atrophy and Neuropathology
Although this study was designed to assess striatal atrophy in clinically defined syndromes, neuropathologic diagnoses became available for 22 of 36 patients. These data (Fig. 2) pointed to intriguing observations that could be explored in future studies. For example, a patient with AD associated with a presenilin-1 mutation showed low striatal volumes compared with the rest of the AD group. Across the bvFTD-associated pathologic spectrum, the most severe striatal atrophy was seen in the patient with FTLD-FUS.
Selected patients with FTLD-tau and FTLD-TDP pathology were examined to explore the pattern of striatal histopathology. Neuron loss, astrogliosis, and focal microvacuolation, especially in ventral striatal regions, were accompanied by robust tau or TDP-43 immunoreactive NCIs and DNs. Strikingly, abundant round, circumscribed TDP-43 immunoreactive NCIs were observed in all patients with SD due to FTLD-TDP, type C (Fig. 3) . These large, round, circumscribed NCIs, recently identified in the putamen, 22 were focally accentuated in the NAcc and are in contrast to the sparse cortical NCIs associated with this FTLD-TDP subtype.
DISCUSSION
Although previous neuroimaging 7, [9] [10] [11] [12] 17, 18, 40, 41 and histopathologic studies [21] [22] [23] have noted general striatal involvement in FTD, this study provides a systematic investigation of striatal subregion atrophy in early bvFTD, SD, and AD. By focusing on specific striatal subregions and using manual volumetric methods better suited to delineate and quantify these structures, we identified panstriatal atrophy in bvFTD and more selective putamen and NAcc atrophy in SD. Severe NAcc degeneration in bvFTD and SD was the most striking and novel finding, in part because previous studies were not designed to assess this subregion. Ventral striatal atrophy correlated with behavioral but not motor deficits and was associated with severe neurodegeneration featuring abundant tau or TDP-43 immunoreactive NCIs, most strikingly in SD due to FTLD-TDP type C. Importantly, overall striatal atrophy was not explained by cortical volume loss alone and was less prominent or absent in patients with AD compared with controls.
Impact of Striatal Atrophy on Behavior
Social, emotional, and behavioral changes represent shared features among patients with bvFTD and SD. 3, 32, 42 Many of these symptoms could relate to striatal or corticostriatal network impairment. The ventral striatum forms a critical node in the dopamine reward system, 43 whose dysfunction in bvFTD and SD may manifest as disinhibited sexual behaviors, food cravings or aversions, changes in substance abuse patterns, and repetitive or compulsive behaviors. 2, [4] [5] [6] Although these symptoms also reflect medial frontal and frontoinsular cortex atrophy common to bvFTD and SD, 9, 44 several recent studies suggest striatal correlations with symptom severity. Gluttonous overeating, for example, correlates with right-sided frontoinsular, but also with right striatal degeneration. 1, 19 Some aberrant motor behaviors, particularly motor stereotypies and hoarding, may reflect striatal involvement. 20, 41 Still, because these previous studies used VBM to quantify striatal volume, subregion localization has not been available. Here, subregional and total striatal atrophy measures were associated with behavioral deficits, even after accounting for overall cortical atrophy.
Dysfunctional eating showed the most subregion-specific relationship, correlating only with the right hemisphere NAcc volume. Although consistent with a previous study, 1 this association did not survive a stringent multiple comparisons correction. Aberrant motor behavior, which in bvFTD and SD most often takes the form of repetitive and compulsive actions, correlated with right-sided striatal degeneration, especially involving the putamen. Overall, our behavioral correlations converge with prior work to suggest that reward-related FTD symptoms reflect right-lateralized ventral striatal circuit dysfunction, especially involving the NAcc and putamen. Extrapyramidal motor deficits, in contrast, showed no correlations with any striatal subregion, most likely because the corticostriatal networks first targeted in bvFTD and SD reflect sociobehavioral rather than motor systems. Furthermore, the early-stage patients included in this study had relatively few motor deficits, which may arise later as nigrostriatal dopaminergic inputs falter. 7
Neuropathologic Correlates of Striatal Degeneration
Abundant striatal tau pathology, manifesting as NCIs, DNs, glial cytoplasmic inclusions, and white matter threads, has been widely reported in patients with FTLD-tau. 23 In this study, we found severe NAcc atrophy in SD, which rarely results from FTLD-tau, 31, 45, 46 and we explored this finding in available neuropathologic materials. Patients with SD due to FTLD-TDP, type C, showed severe striatal degeneration with conspicuous TDP-43 immunoreactive NCIs, especially in the ventral striatum, accompanied by a few DNs coursing through the surrounding neuropil. These findings complement a recent analysis of subcortical pathology in FTLD-TDP, 22 in which similar although perhaps less abundant NCIs were described in the putamen. Largescale regional mapping of TDP-43 pathology further suggested prominent striatal involvement, especially in patients with type C. 24 Thus, in FTLD-TDP, type C, the striatum contrasts with the cortex, which shows few NCIs but prominent long, swollen DNs. 30 Future studies could explore interactions between striatal NCIs and region-specific cortical DNs in patients with SD.
Notably, among patients with pathologic AD, lower ventral striatal volumes were associated with a bvFTD clinical presentation, comorbid dementia with Lewy bodies, or a presenilin-1 mutation. These preliminary observations suggest that striatal atrophy in AD may often relate to atypical disease features. Recent studies suggest that amyloid deposition in presenilin-1-associated AD begins in the striatum, 47 and the atrophy seen in the patient reported here suggests that this early involvement has degenerative consequences. Our data do not suggest, however, that preserved striatal volume alone could predict AD pathology among early age-of-onset patients with behavioral or language syndromes. Some studies have suggested greater striatal pathology in FTLD-tau 16 compared with other FTLD subtypes, perhaps correlating with more severe extrapyramidal motor symptoms in these patients. The present study, however, was based on clinical rather than pathologic groupings and could not determine whether tau pathology was associated with greater motor system-related striatal injury. Interestingly, the most recently described FTLD subtype, FTLD-FUS, 27 is accompanied by severe behavioral derangements and prominent caudate atrophy in vivo 48 and at autopsy. The 1 patient in this study with bvFTD due to autopsyconfirmed FTLD-FUS showed the most severe overall striatal atrophy of any subject (Fig. 2 ).
Relationship Between Striatal Atrophy Patterns and Corticostriatal Connectivity
Human corticostriatal connectivity has been inferred, for the most part, from animal tracer studies. In monkeys, the dorsolateral and the dorsomedial frontal cortices project to a central diagonal band of caudate and putamen, whereas the orbitofrontal, the anterior cingulate, and the temporal polar regions project to the ventromedial caudateputamen and NAcc. 25, 26 The posterior parietal cortex, in contrast, shows only light projections to a strip of dorsolateral caudate-putamen. 49 These projection fields are organized as longitudinal bands running the anteroposterior length of the striatum. Macaque inferotemporal cortex, homologous to a region heavily affected in SD, provides dense inputs to the NAcc and amygdala. 26 Diffusion tensor imaging and functional connectivity MRI studies suggest that human corticostriatal networks parallel those seen in monkeys. [50] [51] [52] Our findings relate closely to these established striatal connectivity patterns. In bvFTD, a disorder affecting medial and orbital cortices, but also the lateral frontal cortex, we found atrophy across all striatal subregions. In SD, which focuses its initial assault on the temporal pole and amygdala 4 before spreading to orbital-insular and medial frontal regions, 53 we found severe ventral striatal involvement. These patterns suggest that striatal subregion atrophy proceeds along connectional lines, reflecting a network-based degeneration cascade. 8 In AD, a posterior hippocampal-cingulo-temporo-parietal syndrome, we detected minimal striatal degeneration, perhaps because AD posterior cortical vulnerability follows corticocortical 54 and corticolimbic, 55 rather than corticostriatal connections. Nonetheless, the mild NAcc atrophy detected in AD may reflect NAcc inputs from the entorhinal/hippocampal regions affected early in AD. 56 
LIMITATIONS
Manual ROI tracing provides the gold standard for volume quantification within structures for which a priori hypotheses can be made. This method, however, has 2 major limitations. First, it is labor intensive, limiting sample size. Although this study confirmed a priori predicted between-group differences, more subtle between-group and within-group effects may have been detectable with larger samples. Second, ROI volumetrics constrain inferences to those regions chosen for the study. Therefore, subtle dorsoventral gradations within the caudate or putamen, for example, would have been missed in this study. In addition, only a subset of our study subjects had standardized prospective motor, behavioral, and neuropsychological data available. Finally, matching for disease severity across clinical diagnoses can prove challenging, although the groups selected here showed no statistical differences in CDR, MMSE, or disease duration. Despite these caveats, our observations highlight the importance of striatal degeneration in FTD pathogenesis and symptoms.
FUTURE DIRECTIONS
Future translational research could capitalize on the well-conserved organization of striatal circuits in rodents. Some functions lost in bvFTD and SD, such as self-conscious emotion, social cognition, and semantic knowledge, cannot be modeled in transgenic animals. Many aspects of ventral striatal function, however, have been largely conserved from mice to humans. Behavioral phenotypes relevant to human overeating and compulsivity have been produced by rodent genetic manipulations, 57, 58 and emerging FTD rodent models could use striatal function as an index of model validity, treatment response, and longitudinal change. Our human data provide an important step toward building this translational interface.
